fda bpc-157 category 2 compounding just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank FDA Adds Several Peptides to
FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting BPC 157 FDA Approval Status 2026: Clinical Trials This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change FDA Peptide Review 2026: What This Big Shift Means
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

